Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

United States Compounding Pharmacies Market Outlook

The United States compounding pharmacies market is being driven by the rising geriatric population and growing demand from parenteral division. The market is expected to grow at a CAGR of 6% in the forecast period of 2024-2032.

United States Compounding Pharmacies Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Geriatric Population Boosting the Compounding Pharmacies Industry Growth

The rising geriatric demographic base, combined with increased longevity, are the primary drivers of market growth. According to the Population Reference Bureau, by 2060, the geriatric population of the United States is expected to account for about 24% of the total population. The population's longevity has risen as the birth rate has decreased and life expectancy has increased. Additionally, the industry's overall development is supported by compounding pharmacies' low costs over the forecast period. A higher percentage of consumers choose compounding pharmacies, as well as an increasing desire to look healthier and younger, has resulted in increased demand for anti-ageing drugs across the United States, consequently favouring the market growth.

Compounding Pharmacies:  Industry Definition and Segmentation

Compounding pharmacies refer to the on-demand distribution of computing resources over the internet, such as storage, servers, applications, and networking, to allow quicker innovation and economies of scale. Customers prefer compounding pharmacies over conventional on-premise deployments because it helps them to pay directly for the resources they need and handle their technology more effectively.

United States Compounding Pharmacies Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on type,  the market is divided into:

  • Oral
  • Topical
  • Suppositories
  • Others

With regards to compounding type, the market is segmented into:

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

On the basis of sterility, the market is bifurcated into:

  • Sterile
  • Non-sterile

By therapeutic area, the market is segregated into:

  • Pain and Management
  • Hormone Replacement Therapy (HRT)
  • Others

Based on distribution channel, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online 
  • Others

By application, the market is segmented into:

  • Pediatric
  • Adult
  • Geriatric
  • Veterinary
  • Others

United States Compounding Pharmacies Market Report and Forecast

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Parenteral Division Fostering the Growth of United States Compounding Pharmacies Industry

The widespread acceptance of compounding pharmacies services, especially public cloud, is expected to boost the market growth of compounding pharmacies in the United States. In 2020, the parenteral division accounted for 18% of the market share of compounding pharmacies in the United States. Compounding ophthalmic treatment drugs, such as glaucoma medications, lower the cost, further boosting the adoption of the product. This has invigorated the market in recent years. Furthermore, compounded dose formulations such as glaucoma reductions assist elderly patients in reducing individual pressure as well as uncertainty about multiple drugs and dosing schedules, thus favouring retail value. Ophthalmic drugs may be administered in a variety of ways, including oral pills, capsules, injections, and drops. As a result, the increasing availability of multiple dosage types in ophthalmic treatment is expected to propel the segment forward. This is predicted to contribute to the overall market growth over the forecast period.

Key Industry Players in the United States Compounding Pharmacies Market

The report gives a detailed analysis of the following key players in the United States compounding pharmacies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Fagron N.V.
  • PharMedium Services, LLC
  • Fresenius Kabi Canada
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Compounding Type
  • Sterility
  • Therapeutic Area
  • Distribution Channel
  • Application
Breakup by Type
  • Oral
  • Topical
  • Suppositories
  • Others
Breakup by Compounding Type
  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others
Breakup by Sterility
  • Sterile
  • Non-sterile
Breakup by Therapeutic Area
  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others
Breakup by Application
  • Pediatric
  • Adult
  • Geriatric 
  • Veterinary 
  • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Fagron N.V.
  • PharMedium Services, LLC
  • Fresenius Kabi Canada
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

United States Compounding Pharmacies Market Report Snapshots

United States Compounding Pharmacies Market Size

United States Compounding Pharmacies Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 6% between 2024 and 2032.

The major drivers of the market are expansion of compounding pharmacies in the country, increasing prevalence of chronic health conditions, easy handling, and low costs of compounding pharmacies.

The key trends influencing the market include the rising geriatric population, increasing costs of doctor visits, and growing availability of multiple dosage types.

Compounding pharmacies are types of pharmacies that are able to dispense combinations of medications for custom requirements of patients.

The significant applications of compounding pharmacies are pediatric, adult, geriatric, and veterinary, among others.

The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online, among others. 

The primary therapeutic areas are pain management, and hormone replacement therapy (HRT), among others.

The various compounding types in the market are pharmaceutical ingredient alteration (PIA), currently unavailable pharmaceutical manufacturing (CUPM), and pharmaceutical dosage alteration (PDA), among others.

Types of compounding pharmacies are oral, topical, and suppositories, among others.

The major players in the United States compounding pharmacies market are Fagron N.V., PharMedium Services, LLC, and Fresenius Kabi Canada, among others.

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,869

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,799

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124